Drug agency seeking to maintain tax benefits for GMP facilities

The Korea Food and Drug Administration has rolled up its sleeves to sustain the tax cut program for the local GMP (Good Manufacturing Practice) facilities, which will be scrapped at the end of this year.

The drug agency has requested the Korea Pharmaceutical Manufacturers Association to submit the basic data covering the GMP facilities, their human resources and expected revenue.

The meas...